November 20, 2019   Gene therapy offering hope for retinal, corneal patients The era of gene therapy in ophthalmology has begun. A treatment for patients with confirmed biallelic RPE65 mutation-associated retinal dystrophy is now available and there are several ongoing studies of gene therapies for inherited and other retinal degenerative diseases. Learn more ADVERTISEMENT   3 questions patients always ask about thermal pulsation therapy Our "Let’s Chat" three-part blog series with Cynthia Matossian, MD, FACS, continues in this second installment. She shed lights on the importance of learning to take about in-office procedures in a way that makes sense to patients, and the top-three questions they often ask. Find out   Toric options offer chance to expand patient’s sweet spot Refractive cataract surgery with premium IOL implants provides a unique opportunity for patients to achieve life-changing vision. However, not all lens platforms, including toric lens platforms, are created equal. Read more

ADVERTISEMENT Glaucoma 360 New Horizons Forum in San Francisco Register to join us at the Grand Hyatt in San Francisco’s Union Square for the 9th Annual New Horizons Forum: speeding the development of new therapies and diagnostics for glaucoma patients. Learn More

RELATED ARTICLES

The future: Development of true accommodative IOLs Addressing common thermal pulsation questions Reshaping medical treatment of glaucoma management Color-LED topography measures corneas consistently in analysis Researchers find long-term statin use linked to lower POAG risk Facing challenge of corneal infection management in operated eyes Pearls for managing care of high-risk uveal melanoma patients

ADVERTISEMENT

Intracameral dexamethasone injection post cataract surgery

In this video, I. Paul Singh, MD, provides tips for administering DEXYCU® (dexamethasone intraocular suspension) 9%. Watch the video now.

JOB OPPORTUNITIES

VT - University of Vermont ADVERTISEMENT